Mavacamten CAS 1642288-47-8 lab use
10 Inquiries
1642288-47-8
Pharmaceutical Grade
99%
qingdao
/
bag
2026-05-08
Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceMavacamten is under investigation in clinical trial NCT03442764 (A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)).
Mavacamten（MYK-461）is a first-in-class allosteric inhibitor of cardiac myosin that promises to provide clinicians with targeted therapy for these patients. It is a mechanistically novel small molecule that acts on the sarcolemma to specifically inhibit contractility and has been proposed as a treatment for HCM.Basic Info-
Product Name:
Mavacamten
Other Name:MYK-461 (SAR-439152);SAR 439152;SAR439152;SAR-439152;SAR-439152; SAR 439152; SAR439152; MYK-461; MYK 461; MYK461; MAVACAMTEN;MYK-461 - Mavacamten | SAR439152;Mavacamten (MYK-461;6-([(1S)-1-phenylethyl]amino)-3-(propan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione
CAS No.:1642288-47-8
Molecular Formula:C15H19N3O2
InChIKeys:RLCLASQCAPXVLM-NSHDSACASA-N
Molecular Weight:273.33
Exact Mass:273.147726857
EC Number:213-161-7
UNII:QX45B99R3J
Color/Form:White to off-white
Categories:
Characteristics-
Density:
1.19±0.1 g/cm3(Predicted)
PKA:8.83±0.40(Predicted)
Critical Temperature & Pressure:Storage temp. -20°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524
-
Location:
RONGSHENG BEIYUANDAJIE 9, LICHENG DISTRICT,JINAN, SHANDONG CHINA
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2022
-
-
Inquiry History10 Inquiries
Country Product Purchase Quantity Date Posted 
India
Mavacamten
10.00 MT Jan 22, 2024
India
MAVACAMTEN API POWDER
25.00 KG Feb 29, 2024
India
MAVACAMTEN
25 KG Feb 28, 2024 
Russia
Mavacamten
100 G Mar 31, 2025 
Australia
Mavacamten
1 MT May 15, 2025
India
Mavacamten
1.00 KG Mar 7, 2024
India
URSODEOXYCHOLIC ACID
10.00 KG Mar 6, 2024
India
Acarbose
10.00 KG Mar 6, 2024
India
Upadacitinib
10.00 KG Mar 6, 2024
India
Ripretinib
10.00 KG Mar 6, 2024 Post an enquiry for this product